Cell-free DNA and preoperative chemoradiotherapy for rectal cancer: a systematic review

Clin Transl Oncol. 2019 Jul;21(7):874-880. doi: 10.1007/s12094-018-1997-y. Epub 2018 Dec 1.

Abstract

Background: Preoperative chemoradiotherapy is the standard of care for patients with locally advanced rectal cancer, yet valid circulating biomarkers are lacking. We aimed at systematically reviewing the literature of cell-free DNA and locally advanced rectal cancer.

Methods: A systematic literature search was performed. We retrieved papers reporting a correlation between a clinical outcome and cell-free DNA for patients receiving chemoradiotherapy for locally advanced rectal cancer.

Results: We included nine studies of a total of 615 patients. Only single-arm studies were identified, analyzing either the total level of cell-free DNA or tumor-specific DNA. Despite differences in the methodology and outcomes, eight of the nine studies showed a correlation between cell-free DNA and a clinical outcome.

Conclusions: Cell-free DNA might hold prognostic and predictive information for patients with locally advanced rectal cancer receiving preoperative chemoradiotherapy; although, firm conclusions are limited by the heterogeneity in this field.

Keywords: Cell-free DNA; Chemoradiotherapy; Rectal cancer; Systematic review.

Publication types

  • Systematic Review

MeSH terms

  • Biomarkers, Tumor / blood*
  • Biomarkers, Tumor / genetics
  • Cell-Free Nucleic Acids / blood*
  • Cell-Free Nucleic Acids / genetics
  • Chemoradiotherapy*
  • Humans
  • Preoperative Care
  • Prognosis
  • Rectal Neoplasms / blood*
  • Rectal Neoplasms / pathology*
  • Rectal Neoplasms / therapy

Substances

  • Biomarkers, Tumor
  • Cell-Free Nucleic Acids